Results 11 to 20 of about 264,190 (272)
Haematologica, 2015 Standard treatment for Glanzmann thrombasthenia, a severe inherited bleeding disorder, is platelet transfusion. Recombinant factor VIIa is reported to be effective in Glanzmann thrombasthenia with platelet antibodies and/or refractoriness to platelet ...
Man-Chiu Poon +5 more
doaj +1 more source
Frontiers in Oncology, 2023 BackgroundMinimal residual disease (MRD) monitoring is an important tool to optimally address post-transplant management of acute myeloid leukemia (AML) patients.MethodsWe retrospectively analyzed the impact of bone marrow CD34+ molecular chimerism and ...
Michele Malagola +18 more
doaj +1 more source
Recurrent Venous Thromboembolism: What Is the Risk and How to Prevent It
Scientifica, 2012 Venous thromboembolism (VTE) that includes deep vein thrombosis and/or pulmonary embolism is a frequent, severe, and potentially lethal disease. After a first episode, VTE has a strong tendency to recur.
Gualtiero Palareti
doaj +1 more source
Platelets, 2018 The purpose of this review is to explore the relationship between platelet bioenergetics and biomechanics and how this relationship affects the clinical interpretation of platelet function devices. Recent experimental and technological advances highlight
Mitchell J. George +6 more
doaj +1 more source
Haematologica, 2015 Standard treatment for Glanzmann thrombasthenia is platelet transfusion. Recombinant activated factor VII has been shown to be successful in patients with Glanzmann thrombasthenia with platelet antibodies or who are refractory to platelet transfusions ...
Giovanni Di Minno +5 more
doaj +1 more source
Evaluation of blood coagulation by optical vortex tracking [PDF]
arXiv, 2021 We investigated a new optical approach for the detection of the coagulation dynamic process by means of the information on the optical vortex. In our study, laser speckle was captured using a high-speed CMOS camera, and the statistical information of the optical vortex characterized the change in coagulation properties with time.
arxiv
The International Prospective Glanzmann Thrombasthenia Registry: Pediatric Treatment and Outcomes
TH Open, 2019 Background Standard treatment for Glanzmann thrombasthenia (GT), a severe inherited bleeding disorder, is platelet transfusion. Recombinant activated factor VII (rFVIIa) is reported to be effective in GT with platelet antibodies and/or refractoriness to ...
Rainer B. Zotz +3 more
doaj +1 more source
ACTION OF HIGH-DISPERSED SILICA ON BLOOD COAGULATION FACTORS ACTIVATION [PDF]
Biotechnologia Acta, 2013 Using of high-dispersed silica based sorbents is a new and prospective method of bleeding arrest. Studies of high-dispersed silica haemostatic action during superficial wounds were promising for its surgery usage. However the mechanisms of haemostatic
T. M. Chernyshenko +6 more
doaj +1 more source
Hemostasis – compendium for students
Journal of Education, Health and Sport, 2020 Hemostasis is one of many well-known systems that ensure a constant conditions of the organism's internal environment. This process is usually divided into two main stages: coagulation and fibrinolysis.
Martyna Kosmalska +2 more
doaj +1 more source
Journal of Innate Immunity, 2022 The coagulation and contact systems are parts of the innate immune system as they prevent bleeding and dissemination of pathogens and also contribute to microbial killing by inflammatory reactions and the release of antimicrobial peptides.
Sonja Oehmcke-Hecht +8 more
doaj +1 more source